NIAID Site Search

DAIDS has a significant regulatory responsibility in the oversight of all its clinical trials.

Last Reviewed: October 30, 2024

Last Reviewed: August 6, 2024

An immune response is generally divided into innate and adaptive immunity. Innate immunity occurs immediately, when circulating innate cells recognize a problem. Adaptive immunity occurs later.

Last Reviewed: January 16, 2014

Last Reviewed: September 12, 2024

Sample grant summary statement from Emily Troemel, Ph.D., for NIH standard independent research project grant (R01).

Last Reviewed: October 11, 2024

Last Reviewed: August 6, 2024

Last Reviewed: August 6, 2024

Last Reviewed: August 6, 2024

NIAID has a long-standing program of research devoted to better understanding, treating, and preventing neglected tropical diseases (NTDs). NIAID conducts its own basic and clinical studies and supports those of researchers based in the United States and in countries where NTDs are widespread. For example, scientists in the Laboratory of Parasitic Diseases are working to uncover how NTD-causing

Last Reviewed: July 17, 2015

NIAID study showed that a vaccine using the same platform being tested in volunteers against Ebola virus also protects African green monkeys exposed to Nipah virus

Last Reviewed: June 16, 2015

Erin Gabriel, Ph.D., is a Mathematical Statistician in the Biostatistics Research Branch at the National Institute of Allergy and Infectious Diseases.

Last Reviewed: June 11, 2018

National Institutes of Health // Food and Drug Administration // Immunology Interest Group

Last Reviewed: September 18, 2024

Last Reviewed: August 6, 2024

Last Reviewed: March 28, 2024

Sample application from Steven W. Dow, D.V.M., Ph.D., for exploratory/developmental grant (R21).

Last Reviewed: May 22, 2024

The mission of NIAID's strategic plan on tuberculosis (TB) research is to accelerate the end of the TB pandemic through research acceleration and innovation.

Last Reviewed: March 15, 2024

Biodefense Meetings and Summaries

Last Reviewed: October 28, 2010

In the BPARS, we apply a systems biology approach to understand selection dynamics and host-pathogen interactions in the context of defined genetic immunodeficiency diseases. This approach integrates genomics, transcriptomics (RNA-seq), and metabolomic methods to identify and characterize specializations that occur during within-host adaptation.

Last Reviewed: January 21, 2025

Last Reviewed: March 28, 2024

National Institutes of Health // Food and Drug Administration // Immunology Interest Group

Last Reviewed: April 16, 2024

Select the links below to learn more about each Division of Intramural Research office, branch, or laboratory. Office of the Director Laboratory of Allergic Diseases Laboratory of Bacteriology Laboratory of Immune System Biology Laboratory of Clinical Immunology and Microbiology Comparative Medicine Branch Laboratory of Host Immunity and Microbiome Laboratory of Virology Laboratory of

Last Reviewed: July 28, 2021

This study will examine the natural history of Leishmanial infections and their treatments. It will provide an opportunity for NIAID staff to learn more about leishmaniasis and perhaps to improve diagnostic tests for these infections.

Last Reviewed: August 6, 2024

Last Reviewed: August 6, 2024

Last Reviewed: August 6, 2024